Cleerly LABS vs Rhythm360
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a detailed, AI-powered anatomical and pathological assessment of coronary arteries. This tool is ideal for precisely quantifying plaque burden, characterizing stenosis, and visualizing coronary anatomy in 3D to inform personalized treatment plans and track disease progression in patients with suspected or known coronary artery disease.
View Cleerly LABS →Choose Rhythm360 if…
Choose Rhythm360 if your clinic requires a comprehensive, vendor-neutral platform to aggregate and manage continuous cardiac monitoring data from various devices. This solution is best suited for reducing alert fatigue, streamlining workflows, and automating billing for remote patient monitoring programs, particularly for patients with hypertension, heart failure, or arrhythmia requiring ongoing surveillance.
View Rhythm360 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Rhythm360 |
|---|---|---|
| Pricing | Varies | Flexible pricing model that scales with clinic size and platform usage. |
| Deployment | Cloud, On-premise | Cloud-based SaaS platform |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rhythm360Rhythm360's focus on unifying diverse cardiac monitoring data, AI-driven alert triage, and a HIPAA-compliant mobile application for clinicians suggests a design optimized for streamlining daily clinical workflows and reducing alert fatigue. Cleerly LABS, while offering powerful 3D visualization, is more specialized for CCTA analysis, which may require a more focused user interaction.
Clinical Value
Cleerly LABSCleerly LABS is FDA-cleared and provides comprehensive, AI-powered analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, aiming to establish a new standard of care for personalized heart disease management and potentially prevent heart attacks. While Rhythm360 offers significant value in managing existing conditions through data aggregation and alert reduction, Cleerly's diagnostic precision and preventative potential represent a more foundational clinical impact.
Pricing & Value
TieCleerly LABS has a transparent, albeit high, per-analysis cost ($750-$1500), often requiring out-of-pocket payment, which can be a barrier to access. Rhythm360 uses a flexible SaaS model that scales with clinic size, but is noted as having 'premium pricing' without specific figures, making a direct value comparison difficult. Both present potential cost challenges, but for different reasons.
Enterprise Readiness
Rhythm360Both tools are cloud-based, HIPAA compliant, and have BAAs. However, Rhythm360 demonstrates superior enterprise readiness through its broad bi-directional EHR integration with multiple major vendors (Epic, Cerner, etc.), vendor-neutral data aggregation from all major cardiac device OEMs, and automated CPT code documentation and billing, which are crucial for large-scale operational efficiency.
Innovation
Cleerly LABSCleerly LABS offers a more fundamental innovation by leveraging AI for FDA-cleared, comprehensive plaque assessment from CCTA, moving beyond traditional stenosis to characterize atherosclerosis and detect ischemia. This aims to create a new standard of care for CAD diagnosis and prevention. Rhythm360's AI for data aggregation and alert triage is innovative for workflow, but Cleerly's approach to redefining a diagnostic standard is a greater paradigm shift.
Support & Docs
Rhythm360Rhythm360 offers a comprehensive support ecosystem, including a knowledge base with support documentation, the ability to create help tickets from within the platform, and an optional 24/7/365 oversight service by certified cardiac technicians. Cleerly LABS provides standard business-hour support with a focus on timely responses but lacks documented self-service resources or advanced operational support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Rhythm360 |
|---|---|---|
| Primary Function/Focus | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. |
| Company | Cleerly | RhythmScience |
| Core Technology/Input | AI-powered CCTA image analysis for comprehensive coronary plaque assessment and stenosis detection. | Vendor-neutral data aggregation from various cardiac monitoring devices. |
| EHR Integration | Integration with PACS, RIS, EHR via Cleerly Proxy. | Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity). |
| Alert Management/Insights | Personalized heart disease risk assessment, tracking disease progression over time. | AI-driven alert triage (80% faster response times, reduces alert fatigue), actionable insights for hypertension, heart failure, and rhythm management. |
| Billing/Coding Support | Not specified | Automated CPT code documentation and billing (e.g., 93298, 93299, 99454, 99453, 99457). |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Rhythm360.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Rhythm360
Backers
Who funded each tool's parent company.